NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
03/13/2026
Back to search
Official data from USPTO
DEGRADABALL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
DEGRADABALL
ST13
US500000079247725Class
1, 5
Filing
79247725
Registration
5905783
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
44
Latest update
03/14/2026
Trademark type
Word
Nice classes
1, 5
Filing date
07/19/2018
Registration date
11/12/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/13/2026
Last transaction
03/14/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
KR
Examiner
CHARLON, BARNEY
Current location
Historical data usage
Holders and representatives
Holders
Lemonex Inc.
Lemonex Inc.
Representatives
Jong H Park The PL Law Group, PLLC
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical stabilizers for use in the manufacture of cosmetics; soil adjuvant for agricultural use; chemicals for use in agriculturehorticulture and forestryexcept fungicidesherbicidesinsecticides and parasiticides; antibody reagents for scientific purposes; active chemical ingredients for use in the manufacture of anti-cancer drugs; active chemical ingredients for use in the manufacture of insecticides; antioxidants for use in the manufacture of cosmetics; antioxidants for use in the manufacture of food and beverages; cell growth media for growing cells for use in scientific research; biochemicals for in vitro and in vivo scientific use; biotechnology reagents for scientific and research use; chemical additives for use in the manufacture of pharmaceuticals; reagents for cell straining for scientific and research use; reagents for cell transformation for scientific and research use; reagents for medical research; reagents for research purposes; silica powder; silicagel powder; silicasol in the nature of a colloid made out of silica particles for use int the manufacture of cosmetics and pharmaceuticals
Class 5
Pharmaceutical and veterinary preparationsa drug delivery system comprising a porous silica particle for the continuous release of a wide variety of therapeutic agents and physiologically active substances; preparations for killing weeds and destroying vermin; Drug delivery agents in the form of porous silica particles that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; radiological contrast substances for medical purposes; radioisotope markers for therapeutic or diagnostic use; radio-isotope markers for therapeutic or diagnostic use; diagnostic reagents and contrast media for medical purposes; skin care preparations for medical purposes; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; reagents for medical use; veterinary preparations for treatment of intestinal bacteria; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
44 publications found
71AG
REGISTERED-SEC.71 ACCEPTED
03/13/2026
PRAN
POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED
03/13/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/09/2026
ES71
TEAS SECTION 71 RECEIVED
11/11/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
11/12/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/21/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/21/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/21/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/21/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/21/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/27/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/05/2020
FIMP
FINAL DISPOSITION PROCESSED
03/05/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/12/2020
CORV
REVIEW OF CORRESPONDENCE COMPLETE - CERTIFICATE OF REG MAILED
12/10/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
11/12/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/27/2019
PUBO
PUBLISHED FOR OPPOSITION
08/27/2019
GPNX
NOTIFICATION PROCESSED BY IB
08/23/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/07/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/07/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/07/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/18/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/27/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/27/2019
ALIE
ASSIGNED TO LIE
06/25/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
06/20/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/02/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/22/2019
GNFR
FINAL REFUSAL E-MAILED
04/22/2019
CNFR
FINAL REFUSAL WRITTEN
04/22/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/30/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/29/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/29/2019
RFNT
REFUSAL PROCESSED BY IB
02/02/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/14/2019
RFRR
REFUSAL PROCESSED BY MPU
01/14/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/03/2019
CNRT
NON-FINAL ACTION WRITTEN
01/02/2019
MAFR
APPLICATION FILING RECEIPT MAILED
01/01/2019
DOCK
ASSIGNED TO EXAMINER
12/26/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/26/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/20/2018
Continuous trademark protection
Get notified about every new filing that threatens DEGRADABALL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.